North America Non-Invasive Cardiac Output Monitoring Device Market

Market Introduction

The measurement of cardiac output (CO) is essential in medical practice. In the past, invasive monitoring with a pulmonary artery catheter (PAC) was the gold standard used to measure CO, but in recent years many minimally invasive or non-invasive devices have been developed to measure CO. Cardiac output gives information about tissue perfusion and oxygen delivery and can identify patients who are at high risk of mortality or morbidity.

Market Overview and Dynamics

The North America non-invasive cardiac output monitoring device market is expected to reach US$ 129,912.44 thousand by 2027 from US$ 95,471.09 thousand in 2020; it is expected to grow at a CAGR of 5.1% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases and rise in geriatric population. However, the high cost of the device hinders the market growth.

In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. According to the estimates of the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds due to cardiovascular diseases (CVD) in the US. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices. Similarly, geriatric populations are susceptible to many chronic diseases. Most of them suffer from multiple diseases such as diabetes, heart diseases, and pulmonary diseases and some of them undergo surgeries. Non-invasive cardiac output (CO) monitoring is one of the important modern medical practices used while observing critically ill patients. As per the data from World Population Prospects: the 2019 Revision, one in four people in North America would be aged 65 or more by 2050. Moreover, the number of people aged 80 years and above is projected to increase by three-folds from 143 million in 2019 to 426 million by 2050. Thus, increasing geriatric population favours the growth of the market.

Key Market Segments

Based on device, the North America non-invasive cardiac output monitoring device market is segmented into patches, wristwatches, and probes & catheters. The probes & catheters segment held the largest share of the market in 2019. However, the wristwatches segment is estimated to register the highest CAGR in the market during the forecast period.

Based on indication, the North America non-invasive cardiac output monitoring device market is segmented into hypertension, coronary diseases, congenital problems, myocardial ischemia and infarction, heart failure, arrhythmias, and others. The hypertension segment held the largest share of the market in 2019. However, the heart failure segment is estimated to register the highest CAGR in the market during the forecast period.

Based on end user, the North America non-invasive cardiac output monitoring device market is segmented into hospitals, emergency services centers, homecare, and others. The hospitals segment held the largest share of the market in 2019. However, the emergency services centers segment is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the North America non-invasive cardiac output monitoring device market are the U.S Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and American Heart Association (AHA).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of North America non-invasive cardiac output monitoring device market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the North America non-invasive cardiac output monitoring device market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America non-invasive cardiac output monitoring device market.

NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICE MARKET SEGMENTATION

By Device

• Patches
• Wristwatches
• Probes & Catheters

By Indication

• Hypertension
• Coronary Diseases
• Congenital Problems
• Myocardial Ischemia and Infarction
• Heart Failure
• Arrhythmias
• Others

By End User

• Hospitals
• Emergency Services Centers
• Homecare
• Others

By Country

• US
• Canada
• Mexico

Company Profiles

• General Electric Company
• Koninklijke Philips N.V.
• Abbott
• DELTEX MEDICAL
• LiDCO
• CONMED Corporation
• ImaCor
• NIMedical
• Baxter International Inc.

North America Non-Invasive Cardiac Output Monitoring Device Market Strategic Insights

North America Non-Invasive Cardiac Output Monitoring Device Market Segmentation Analysis

North America Non-Invasive Cardiac Output Monitoring Device Market Report Highlights

North America Non-Invasive Cardiac Output Monitoring Device Report Scope

North America Non-Invasive Cardiac Output Monitoring Device Market Country and Regional Insights